| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
40,253 |
37,895 |
$2.90M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
20,954 |
19,963 |
$1.65M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,378 |
21,325 |
$1.57M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
20,469 |
19,362 |
$1.37M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,668 |
1,567 |
$102K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,162 |
2,740 |
$91K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
721 |
657 |
$42K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,000 |
1,858 |
$20K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,716 |
1,511 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
331 |
298 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
556 |
407 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,239 |
1,009 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
2,114 |
1,814 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
557 |
469 |
$1K |
| 81003 |
|
588 |
521 |
$504.24 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
138 |
111 |
$498.24 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13 |
13 |
$413.71 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
708 |
596 |
$372.57 |
| 94760 |
|
146 |
140 |
$102.96 |
| 85004 |
|
606 |
528 |
$96.44 |
| 99000 |
|
725 |
705 |
$70.10 |
| 81025 |
|
14 |
13 |
$51.24 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
65 |
58 |
$5.45 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
48 |
26 |
$0.96 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.26 |
| A9150 |
Non-prescription drugs |
59 |
47 |
$0.00 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
23 |
21 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
545 |
481 |
$0.00 |